Literature DB >> 20865467

Epidemiological classification and social impact of chronic headache.

Gian Camillo Manzoni1, Paola Torelli.   

Abstract

The current prevalent opinion is that a diagnosis of chronic headache should be established in patients who have had a form of primary headache other than cluster headache on at least 15 days a month for at least 3 months. Chronic headache so defined includes four different subtypes: hemicrania continua and new daily persistent headache--two rare forms currently included in the group "Other primary headaches" of the 2004 International Classification of Headache Disorders, second edition (ICHD-II)--chronic tension-type headache, and chronic migraine. Regarding the latter, which has been better known lately as transformed migraine, the current revised diagnostic criteria establish that migraine must be present on at least 8 of the at least 15 days of headache per month and that there must not be any overuse of symptomatic medication. Chronic headache affects about 3-5% of the general population and results in a variety of negative repercussions both on individuals and on society at large.

Entities:  

Mesh:

Year:  2010        PMID: 20865467     DOI: 10.1007/s11739-010-0444-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  5 in total

Review 1.  Nocebo in headaches: implications for clinical practice and trial design.

Authors:  Dimos D Mitsikostas
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 2.  Outcome of Chronic Daily Headache or Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 3.  Efficacy of mindfulness-based intervention for the treatment of chronic headaches: A systematic review and meta-analysis.

Authors:  Muhammad Aemaz Ur Rehman; Radeyah Waseem; Ume Habiba; Muhammad Fahad Wasim; Soha Alam Rehmani; Maha Alam Rehmani; Maryam Abdullah; Yumna Khabir; Mahnoor Rehan Hashmi; Talal Almas; Syed Shahan Ali; Syed Muhammad Huzaifa Shah; Kaneez Fatima
Journal:  Ann Med Surg (Lond)       Date:  2022-05-27

Review 4.  Anti-CGRP monoclonal antibodies in migraine: current perspectives.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Martina Curto; Andrea Negro; Raffaele Costantini; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2016-06-23       Impact factor: 3.397

Review 5.  Chronic migraine classification: current knowledge and future perspectives.

Authors:  Gian Camillo Manzoni; Vincenzo Bonavita; Gennaro Bussone; Pietro Cortelli; Maria Carola Narbone; Sabina Cevoli; Domenico D'Amico; Roberto De Simone; Paola Torelli
Journal:  J Headache Pain       Date:  2011-10-26       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.